5410 semaglutide Receives FDA Approval for Treatment of MASH SpaDerma | Semaglutide | Tirzepatide

We accept a variety of insurance plans, manage prior authorizations, and offer comprehensive care coordination

The Wegovy pill is now available in the UK, following MHRA approval

Combining genetic pathway insights with clinical monitoring data (weight, BP, renal function, HbA1c) empowers a more informed conversation with your provider about whether to continue, adjust, or potentially discontinue aspirin or anticoagulant therapy as your metabolic health improves on compounded GLP-1 treatment

Clinical studies indicate that stopping GLP-1 therapy abruptly can lead to weight regain due to hormonal and metabolic adaptations

Signs you might not be eating enough on Wegovy: Feeling dizzy or lightheaded when standing up Difficulty concentrating or brain fog Feeling cold more often than usual Extreme fatigue after minimal activity Mood changes including irritability Hair loss or brittle nails Practical strategies to ensure adequate nutrition: 1

But it is not the entire picture